Nishant Pandey

Mr. Nishant Pandey

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2026 in Journal of Gandaki Medical College-Nepal
Verified
Journal Article
Open access
APAngana Parajuli
Angana Parajuli
NPNishant Pandey
Nishant Pandey
SJSulav Kumar Jha
Sulav Kumar Jha
BDBistrit Dahal
Bistrit Dahal
SGShreya Gautam
Shreya Gautam
Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Acute exacerbations frequently lead to emergency visits and worsen patient outcomes. This study aimed to assess the clinical presentation, precipitating factors, and predictors of severity among patients with AECOPD (Acute exacerbation of chronic obstructive pulmonary disease). Methods: A descriptive cross-sectional study was conducted among 150 patients presenting with AECOPD to the emergency department of a tertiary care center in Pokhara, Nepal. Data on clinical features, risk factors, and investigations were collected and analyzed using SPSS 25.0. Multivariable logistic regression was used to identify predictors of ICU admission. Results: The mean age was 75.6±9.8 years, with female predominance 92(61.3%). Shortness of breath 147(98%) and cough 125(83.3%) were the most common symptoms. Recent upper respiratory tract infection 38(25.3%) was the most frequent trigger. ICU admission was required in 42(28%) of patients. Increased respiratory rate, lower oxygen saturation, cyanosis, and accessory muscle use were associated with severity. Respiratory rate, PaO₂, and serum creatinine were independent predictors of ICU admission. Conclusions: AECOPD mainly affects elderly patients and is commonly triggered by infections. Simple clinical and laboratory parameters can help identify severe cases early, allowing timely management and improved outcomes.

13 October 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MJMandeep D. Joshi
Mandeep D. Joshi
NPNishant Pandey
Nishant Pandey
KKkenedy khatri
kenedy khatri
AKAvinash Kc
Avinash Kc
RTRam Thapa
Ram Thapa
Introduction: Intramuscular lipomas (IMLs) are rare, comprising less than 1% of all lipomas, and typically arise in large proximal muscles. Their occurrence in the calf is extremely uncommon and may mimic vascular or malignant lesions on imaging. Case Presentation: A 45-year-old female presented with an 8-month history of dull pain in the left calf. MRI suggested a hemangioma. Surgical excision was performed, and histopathology confirmed an intramuscular lipoma. The patient recovered without complications and reported full symptom resolution. Clinical Discussion: IMLs in distal sites like the calf are rare and challenging to diagnose due to imaging overlap with hemangiomas and liposarcomas. MRI aids evaluation, but histopathology remains the gold standard. Surgical excision is curative, and biopsy may be omitted in select small, radiologically benign lesions to avoid contamination. Conclusion: IMLs should be considered in the differential diagnosis of painful intramuscular masses, even in atypical locations. Accurate diagnosis and complete excision ensure favorable outcomes.

6 April 2026 in Clinical Case Reports
Verified
Journal Article
Open access
DBDr. Aayush Bist
Dr. Aayush Bist
NPNishant Pandey
Nishant Pandey
MJMukund Raj Joshi
Mukund Raj Joshi
Hepatic cystic lesions pose diagnostic challenges due to overlapping imaging features, as simple hepatic cysts may mimic biliary cystadenoma or hydatid cysts. We report a 43‐year‐old female with chronic right lower abdominal pain, initially diagnosed with hydatid cyst on ultrasonography and later suspected as biliary cystadenoma on CT and MRI. She underwent laparotomy with cyst excision and cholecystectomy, but histopathology confirmed a simple hepatic cyst. This case highlights the limitations of radiology in differentiating hepatic cystic lesions, the crucial role of histopathology—particularly the absence of ovarian‐like stroma—in establishing diagnosis, and the importance of imaging‐pathology correlation for accurate management and avoiding inappropriate treatment.

5 October 2026 in Nepal Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
IBIndrajit Banerjee
Indrajit Banerjee
JRJared Robinson
Jared Robinson
KMKrissheeven Mooroogiah
Krissheeven Mooroogiah
NPNishant Pandey
Nishant Pandey
SBShradha Banerjee
Shradha Banerjee
IBIndraneel Banerjee
Indraneel Banerjee
Tavapadon is a novel, highly selective D1/D5 partial dopamine agonist with little activity at D2/D3 receptors. This systematic review was undertaken to assess the efficacy and safety of tavapadon in Parkinson’s disease and to better define its overall therapeutic potential. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines were implemented during the conduct of this systematic review and were prospectively registered with the International Prospective Register of Systematic Reviews (PROSPERO) under registration number CRD420261489191. All RCTs on Tavapadon in Pakinsons disease from 2010 to 2026 were searched and evaluated against specific eligibility criteria and were included in this systematic review. The part III MDS-UPDRS ranged from -9.0 to 11 for Tavapadon and from -4.3 to 4.6 for placebo. For part I MDS-UPDRS, Tavapadon ranged from -0.2 to 1.4 and Placebo ranged from 0 to 1. Part II and part III combined MDS-UPDRS, Tavapadon ranged from -10.3 to 10.3 and placebo ranged from -1.2 to 4.7. Tavapadon showed more adverse effects compared to placebo viz. nausea, headache, dry mouth, tremors, constipation, dyspepsia, salivary hypersecretion, fatigue, dizziness and hallucinations whereas placebo showed more tremors. It is evident that the novel drug Tavapadon has shown improved motor as well as Unified Parkinson's Disease Rating Scale scores as when compared to the placebo. Similarly Tavapadon has also shown to have a host of side effects which are expected in drugs acting on the dopaminergic receptors. Further investigation will be needed to take place in order to establish the clinical efficacy as well as the adverse effects profile of Tavapadon and traditional Dopaminergic drugs in head to head comparison studies.

5 October 2026 in Nepal Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
IBIndrajit Banerjee
Indrajit Banerjee
KMKrissheeven Mooroogiah
Krissheeven Mooroogiah
JRJared Robinson
Jared Robinson
NPNishant Pandey
Nishant Pandey
SBShradha Banerjee
Shradha Banerjee
IBIndraneel Bannerjee
Indraneel Bannerjee
Background: Polyendocrine metabolic ovarian syndrome (PMOS), formerly referred to as polycystic ovary syndrome (PCOS), is among the most common endocrine disorders in women of reproductive age. Methods: An extensive literature search was done on Cochrane, PubMed, TRIP and Google Scholar. Pooled effect estimates were calculated using a fixed-effect model (I250 %). Result: The combination of metformin and liraglutide was associated with significantly lower fasting blood glucose level as compared to mono-therapy [MD]= -0.19 mmol/L, 95% CI: -0.33-0.06 mmol/l, Z=2.79, P=0.005, χ²=6.08, df=3, P=0.11, I2=0%). The combination of drugs significantly increased sex hormone binding globulin as compared to monotherapy [MD]= 7.89L, 95% CI 3.80-11.99, Z=3.78, P=0.0002, χ²=1.74, df=1, P=0.19, I2=42%). The pooled analysis demonstrated that metformin significantly reduced the risk of nausea as compared to the Metformin and liraglutide combination (RR=8.30 95% CI: 2.64, 26.10, Z=3.62, P=0.0003, χ²=0.43, df=2, p=0.80, I2 =0%). Conclusion: The combination of liraglutide and metformin was found to be advantageous over metformin in monotherapy, with respect to improving the patient’s glycaemic control by inducing a significant reduction in the fasting blood glucose level as compared to monotherapy. The combination therapy also significantly increased sex hormone binding globulin, such hormonal control is an underpinning facet in the treatment of PMOS and therefore this finding advocates for the use of metformin and liraglutide in combination.

22 October 2026 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
ASAlisha Surkheti
Alisha Surkheti
NPNishant Pandey
Nishant Pandey
BGBibek Ghimire
Bibek Ghimire
SSSagun Sapkota
Sagun Sapkota
BPBijaya Poudel
Bijaya Poudel
BBBishal Banmala
Bishal Banmala
Background: Ortner’s syndrome, or cardiovocal syndrome, is an uncommon cause of recurrent laryngeal nerve palsy due to cardiovascular pathology. Thoracic aortic aneurysm is a rare but important etiology that may present only with hoarseness. Case presentation: An 85-year-old man with hypertension and a history of chronic smoking presented with progressive hoarseness for 1 month. Flexible laryngoscopy showed paralysis of the left vocal cord without laryngeal pathology. Contrast-enhanced computed tomography (CT) revealed a 22 × 17 mm saccular aneurysm arising from the distal aortic arch at the aortopulmonary window, with mural thrombus and in close proximity to the left recurrent laryngeal nerve. No cervical, mediastinal, pulmonary, or laryngeal malignancy was detected. Echocardiography showed preserved systolic function without significant valvular disease or pulmonary hypertension. Ortner’s syndrome associated with the distal aortic arch aneurysm was considered the most likely diagnosis based on the clinical and radiological findings and the exclusion of other identifiable causes. Surgical repair was advised, but the patient declined and was managed conservatively. At the 11-month clinical follow-up, he remained stable with persistent hoarseness; no follow-up CT was performed. Clinical discussion: Aortic arch aneurysm is a rare cause of Ortner’s syndrome and may mimic more common causes of unilateral vocal cord paralysis, particularly malignancy. Imaging along the recurrent laryngeal nerve pathway, including the thorax, is essential when laryngoscopy does not reveal a local cause. Conclusion: Unexplained left vocal cord paralysis should prompt an evaluation for cardiovascular causes. Early cross-sectional imaging can identify a thoracic aortic aneurysm and guide timely multidisciplinary management.